Galliford Try up as it rejects Bovis approach for subsidiary
The price of shares in housebuilder Galliford Try has risen after it confirmed that it had received a preliminary proposal from FTSE 250 rival Bovis Homes.
The price of shares in housebuilder Galliford Try has risen after it confirmed that it had received a preliminary proposal from FTSE 250 rival Bovis Homes.
FTSE 250 guarantor loans lender Amigo Holdings has seen its share price climb by 5.50% after revenues increased by 28.4% over the year ended 31st March.
AIM-listed Oxford Biodynamics has seen its share price drop by 4.62% after its operationg loss for the six months to 31st March widened to £1.7 million.
FTSE 250 precision instruments manufacturer Spectris saw its share price rise by 2.17% as like-for-like sales rose by 3% over the four months of 2019.
AIM-listed drug discovery firm Immupharma reported a loss of £7.2 million for the year ended 31st December, up from a £6.2 million loss in the prior year.
Choose your ISA funds with our expert’s guidance – Fidelity’s Tom Stevenson gives his fund picks for 2019.
The trade war between China and the USA has entered a new and more dangerous phase which could have serious implications for the global financial system. What’s more, it presages the start of something graver: a New Cold War, writes Victor Hill.
AIM-listed supply chain specialist Tungsten Corporation increased its revenues for the year ended 30th April by 7%.
Quality assurance giant Intertek has reported that revenues for the four months ended 30th April rose by 5.3%, driven by the trade and products arm.
FTSE 250 pub operator Mitchells & Butler has seen its share price climb by 8.45% after revenues rose 5.0% during the 28 weeks to 13th April.